The Enhanced 20% Credit Rate: A Strategic Analysis of the Delaware R&D Tax Credit for Small Businesses

Executive Summary

The 20% Credit Rate (Small Business Alternative) dramatically increases the benefit available under the Delaware Research and Development (R&D) Tax Credit. This provision allows qualified small businesses—defined as those with average annual gross receipts not exceeding $20 million—to claim double the standard incentive rate against their qualified research expenditures.

This enhanced incentive is fully refundable, meaning any credit amount that surpasses the company’s Delaware tax liability is disbursed directly to the taxpayer as a cash refund. This feature positions the credit as a crucial mechanism for generating non-dilutive working capital for R&D-intensive startups and growing small firms operating within the state.1

Introduction: Elevating Small Business R&D Investment in Delaware

Delaware provides one of the most compelling state-level R&D tax incentives in the United States, structured specifically to encourage innovation within its borders. The legislative foundation for this credit resides in Title 30, Chapter 20, Subchapter VIII of the Delaware Code, specifically $\S 2070$, which outlines the amount of credit and applicable procedures.2

The state’s R&D tax program is unique due to its high incentive rates and the crucial commitment to full refundability.1 For small businesses, this incentive is further amplified through the “Alternative Calculation for Small Businesses” provision in $\S 2070(a)(2)$, which doubles the credit rates available under both primary calculation methods.

A. Legislative Authority and Scope

The framework of the Delaware R&D tax credit is inextricably linked to the federal R&D tax credit defined under Internal Revenue Code (IRC) $\S 41$.3 This linkage means that any R&D activity conducted within Delaware that qualifies for the federal credit automatically qualifies for the state credit.3

Taxpayers have the flexibility to calculate their Delaware credit using one of two independent methodologies—Method A or Method B—which must be elected annually and does not need to align with the method chosen for the federal credit calculation.3

The financial structure of the credit offers a significant advantage: full refundability. If the approved credit amount exceeds the taxpayer’s Delaware income tax liability for the taxable year, the statute explicitly mandates that the unused credit “shall be paid to it in the nature of a tax refund”.2 This feature is particularly valuable to early-stage technology and life science companies that often incur substantial R&D costs long before they generate taxable income.

I. Qualification for the 20% Small Business Alternative

Accessing the enhanced 20% credit rate under Method A, or the corresponding 100% utilization rate under Method B, requires strict adherence to Delaware’s definition of a “small business.”

A. Defining the “Small Business” Threshold

The enhanced credit rates are exclusively reserved for taxpayers meeting the statutory requirements set forth in $\S 2070(a)(2)$.2

The qualification criterion specifies that a “small business” is defined as any taxpayer whose average annual gross receipts (AAGR), as determined by reference to IRC $\S 41(c)(1)(B)$, are not in excess of the applicable threshold of $20,000,000.1 This AAGR calculation typically involves averaging the gross receipts reported over the four taxable years preceding the credit year. Taxpayers must conform to this $20 million threshold, regardless of which method they use to compute their federal R&D tax credit.2

The Delaware Division of Revenue (DOR) administers various taxes, including the state’s unique Gross Receipts Tax (GRT), which is levied on the total gross revenues generated from the sale of goods or provision of services within the state.9 The DOR’s interpretation of “gross receipts” for GRT purposes is extremely broad, excluding deductions for costs of goods sold, labor costs, interest, or other expenses.9 While the R&D credit statute refers to the federal mechanism for calculating AAGR, the overall rigorous approach to revenue reporting in Delaware necessitates meticulous accounting practices to accurately establish compliance with the $20 million AAGR cap, especially for entities operating across multiple states.

B. The $20 Million Threshold and Financial Modeling

The $20 million AAGR threshold serves as a critical boundary, creating a substantial financial consequence for growing enterprises. For a qualified small business, the incentive rates are doubled: Method A utilizes 20% instead of 10%, and Method B utilizes 100% instead of 50%.3

Should a business slightly exceed this $20 million threshold, for example, moving from $19.9 million to $20.1 million AAGR, the company instantaneously loses the enhanced rate structure. This means the resulting refundable credit could be halved, leading to an abrupt and significant decrease in the company’s expected cash inflow from the R&D incentive.

For tax directors and CFOs of scaling businesses, this dynamic underscores the necessity of precise financial forecasting. Strategic tax planning must integrate growth projections with the statutory definition of average annual gross receipts to prevent inadvertently exceeding the threshold and suffering a massive reduction in recoverable tax assets. The potential drop in the refundable credit is directly proportional to the doubling of the available rate, highlighting the sharp non-linear risk associated with the specific dollar threshold.

II. Calculation Method A: The 20% Enhanced Incremental Credit

Calculation Method A is based on the traditional incremental approach, rewarding the increase in Delaware Qualified Research Expenses (QREs) over a historical base amount. For small businesses, this methodology applies the enhanced 20% rate.

The general formula for Method A is:

$$\text{Method A Credit} = 20\% \times (\text{Current DE QREs} – \text{Delaware Base Amount})$$

A. The Complex Calculation of the Delaware Base Amount

The critical variable in Method A is the Delaware Base Amount. This figure is calculated using a fixed-base percentage (FBP) system, which mirrors the complex federal calculation requirements but is localized to Delaware-specific data.3

1. Fixed-Base Percentage (FBP): The FBP is determined by establishing the ratio of total Delaware QREs to total Delaware Gross Receipts over the four tax years immediately preceding the credit year.3 If a company has not been in operation for four years, or lacks QRE and gross receipts data for the full period, the calculation utilizes the available preceding years.3 For a company with no prior QRE history, the FBP is effectively zero.3
2. Average Annual Gross Receipts (AAGR): This is the simple arithmetic average of the taxpayer’s Delaware Gross Receipts over the four tax years preceding the credit year.3
3. Base Amount Determination: The calculated Delaware Base Amount is the product of these two components: FBP multiplied by AAGR.3

B. The Minimum Base Rule: The 50% Floor

A pivotal statutory constraint on Method A is the mandated minimum base requirement, which substantially limits the amount of QREs eligible for the credit.3

The final Delaware Base Amount used in the credit calculation must be the greater of the historically calculated Base Amount (FBP $\times$ AAGR) or 50% of the current year’s Delaware QREs.3

This provision establishes a high threshold, ensuring that at least 50% of the current year’s R&D expenses are excluded from the “excess QREs” on which the credit is calculated. This limitation is sometimes referred to as the 50% floor. The immediate effect of this floor is that even if a business has zero historical R&D expenses (yielding a zero FBP), the credit base is capped at 50% of current QREs. Consequently, the maximum effective credit rate for Method A is 20% of 50% of QREs, or 10% of total current QREs.

C. Applying the Enhanced 20% Rate

Once the Delaware Base Amount is determined (always subject to the 50% minimum floor), the small business calculates the difference, known as the “Excess QREs.” The statutory relief for small businesses dictates that the normal 10% rate applied to these excess expenses is substituted with a 20% rate.8 This substitution doubles the credit yield compared to a larger, non-qualifying business utilizing the same QRE base.3

The ability to apply the 20% rate to the calculated Excess QREs provides a significant incentive for small businesses to sustain or increase their R&D investment within the state.

D. The Trade-Off Between Rate and Base

While the 20% rate under Method A is numerically superior to the 10% standard rate, the calculation methodology imposes inherent constraints on the credit base. The mandatory 50% QRE floor ensures that a substantial portion of current R&D spending is excluded from the calculation.

This structural constraint often requires small businesses to perform an essential optimization analysis comparing Method A with Method B (the Alternative Simplified Credit approach). The 20% rate provides a high percentage, but only against a narrow base (at most, 50% of current QREs). If a company is experiencing aggressive growth in QREs year-over-year, the Alternative Simplified Credit method (Method B) might offer access to a wider credit base, even if the utilization rate itself appears lower. The flexibility of Delaware law, which permits an independent, annual election of the calculation method 2, allows tax planning professionals to select the method that maximizes cash recovery each year based on the firm’s specific R&D expenditure trajectory.

III. Calculation Method B: The 100% Alternative Simplified Credit (ASC)

As an alternative to the complex fixed-base calculation of Method A, small businesses may elect Method B, which ties the state credit directly to the federal Alternative Simplified Credit (ASC) framework. This option provides a comparable, and often greater, benefit structure for growing firms.

A. Federal ASC and Delaware Apportionment

The federal R&D tax credit permits the use of the ASC method (IRC $\S 41(c)(5)$), which eliminates the need to calculate the historical fixed-base percentage. Instead, the ASC bases the credit on current QREs exceeding 50% of the QRE average from the previous three tax years.13 Federally, the ASC rate is 14%.13

For standard businesses in Delaware, Method B allows claiming 50% of the state’s apportioned share of the resulting federal ASC.3 However, for small businesses that meet the under $20 million AAGR threshold, the statute provides a substitution, allowing the business to claim 100% of Delaware’s apportioned share of the federal ASC.2 This utilization factor is double the standard rate.

B. Apportionment Mechanics

The federal ASC is calculated based on total nationwide qualified research expenditures. Delaware requires an apportionment calculation to properly assign the credit liability only to research activities conducted within its state boundaries.2

The apportionment factor is calculated as the ratio of Delaware QREs to the taxpayer’s total nationwide QREs for the taxable year.2

$$\text{Delaware Apportioned Share} = \text{Federal ASC} \times \frac{\text{Delaware QREs}}{\text{Total Nationwide QREs}}$$

For a small business, the final state credit is calculated as 100% of this Delaware Apportioned Share. For example, if a small biotechnology firm has a total calculated federal ASC of $200,000 and 75% of its QREs were performed in Delaware, the state credit under Method B would be 100% of ($200,000 $\times$ 75%), equaling $150,000.

C. Strategic Decision Point: Method A (20%) vs. Method B (100% ASC)

The annual flexibility to choose between Method A and Method B is a crucial aspect of Delaware tax planning.2 The optimal method often depends on the business’s QRE history and growth velocity.

Table 1: Delaware R&D Credit Calculation Rate Comparison

Method A’s 20% rate appears higher, but the effective credit base is strictly limited by the 50% floor on current QREs. In contrast, Method B, which utilizes the federal ASC base, often rewards companies with rapidly accelerating R&D expenditures. The ASC base is determined by comparing current QREs to the average QREs of the prior three years.13 If current R&D spending significantly outpaces the 3-year average, the incremental amount qualifying for the ASC calculation (and thus the 100% Delaware utilization) can be larger than the capped 50% base under Method A. Taxpayers must run parallel calculations to ensure the most beneficial method is elected each year.

IV. Delaware Division of Revenue (DOR) Compliance and Filing Requirements

The enhanced 20% R&D credit is subject to specific administrative procedures enforced by the Delaware Division of Revenue (DOR). Compliance requires timely filing and the submission of required federal documentation.

A. Required Administrative Forms and Documentation

The process is initiated via a mandatory application to the DOR.

1. Form 2070AC: The taxpayer must complete and submit Delaware Form 2070AC, the “Application and Computation Schedule for Claiming Delaware Research and Development Tax Credits”.11 Part B of this form requires the taxpayer to explicitly select and detail the chosen computation method (Method A or Method B).11
2. Mandatory Federal Form: A critical requirement for the application is the attachment of the federal research credit Form 6765 (Credit for Increasing Research Activities). This federal form substantiates the QREs and the methodology used federally, confirming the taxpayer’s underlying eligibility for the state credit.6 If a consolidated corporate income tax return is filed, a proforma Form 6765 for the applicant corporation must be attached.11
3. Filing Deadline: The application (Form 2070AC) must be received by the DOR on or before September 15th following the end of the taxable year during which the qualified R&D expenses were incurred.1 This is a definitive, statutory deadline essential for credit approval.

B. Credit Utilization and Refund Mechanism

Upon approval of the credit amount by the DOR, the taxpayer proceeds to utilize the credit against their tax liability.

The approved credit amount detailed on Form 2070AC is transferred to Delaware Form 700, the Delaware Income Tax Credit Schedule.11 C-corporations enter the amount directly, while S-corporations must multiply the credit by each shareholder’s percentage of stock ownership for allocation purposes.11

The fundamental advantage of the Delaware credit is its refundability. If the calculated and approved credit exceeds the taxpayer’s qualified tax liability, the statute guarantees that the excess credit “shall be paid to it in the nature of a tax refund”.2 This feature is a significant differentiating factor, converting a tax reduction measure into a direct cash injection for small, growing companies.

C. Navigating the Annual Statewide Cap

Although the credit is fully refundable and generous, taxpayers must be aware of a statutory mechanism that can reduce their final receivable amount: the statewide annual cap.

The statute imposes an aggregate annual limit of $5,000,000 on the total amount of R&D tax credits that can be approved for all taxpayers in any given fiscal year.11 If the sum of all eligible R&D credits applied for by all taxpayers exceeds this $5 million cap, the DOR must prorate the total available credit among all applicants. Each applicant’s approved credit will be the product of $5,000,000 multiplied by a fraction, where the numerator is the applicant’s eligible R&D credit and the denominator is the total of all eligible R&D credits applied for by all applicants.11

Analysis of available financial reports, such as the Delaware Tax Preference Report, reveals that the estimated annual revenue loss attributed to this tax preference is significantly higher, potentially ranging from $20.0 million to $26.0 million in Fiscal Year 2024.15 The discrepancy between the $5 million cap and the actual estimated economic impact suggests that the annual applications likely exceed the statutory limit, making the proration mechanism a genuine risk. Therefore, timely and accurate filing by the September 15th deadline is not merely a compliance requirement but a critical strategic step to ensure the application is processed efficiently and receives the full eligible amount before proration calculations are finalized.

V. Comprehensive Case Study: Maximizing the 20% Credit Rate

To illustrate the application of Method A (20% Enhanced Incremental Credit) and its financial impact, a comprehensive scenario for a small business, Horizon Tech Solutions, is presented.

A. Scenario Overview: Horizon Tech Solutions

Horizon Tech Solutions is an innovative Delaware-based C-Corporation that qualifies as a small business. The company is determining its R&D tax credit for the current taxable year (TY 2024).

B. Step-by-Step Calculation Using the 20% Method A

The analysis uses the fixed-base percentage calculation, subject to the mandated 50% minimum QRE floor, and applies the enhanced 20% rate.

1. Calculate Fixed-Base Percentage (FBP): The FBP represents the historical R&D intensity relative to gross receipts over the four preceding years.11

$$\text{FBP} = \frac{\text{Historical DE QREs}}{\text{Historical DE Gross Receipts}} = \frac{\$3,000,000}{\$60,000,000} = 0.05 \text{ or } 5.0\%$$

1. Calculate Historical Delaware Base Amount (DBA): This is the projected base R&D expense based on historical activity.11

$$\text{Calculated DBA} = \text{FBP} \times \text{AAGR} = 5.0\% \times \$15,000,000 = \$750,000 \quad \text{(B)}$$

1. Apply Minimum Base Rule (50% Floor): The floor mandates that the base amount must be at least 50% of the current year’s QREs.3

$$\text{Minimum Base} = 50\% \times \text{Current DE QREs} = 50\% \times \$1,500,000 = \$750,000 \quad \text{(C)}$$

1. Determine Final Delaware Base Amount Used: The final base amount is the greater of the calculated DBA or the Minimum Base.11

In this scenario, the calculated DBA ($750,000) is equal to the minimum base ($750,000).

$$\text{Final Base Amount} = \$750,000 \quad \text{(D)}$$

1. Calculate Excess QREs: The credit is calculated only on the expenses exceeding the final base amount.11

$$\text{Excess QREs} = \text{Current DE QREs} – \text{Final Base Amount} = \$1,500,000 – \$750,000 = \$750,000 \quad \text{(E)}$$

1. Apply the Enhanced Small Business Credit Rate (20%): The 20% rate is applied because the business qualifies as a small business.8

$$\text{Delaware R\&D Credit} = 20\% \times \text{Excess QREs} = 20\% \times \$750,000 = \mathbf{\$150,000}$$

Table 2: Calculation of the 20% Small Business R&D Credit (Method A)

C. Financial Impact and Refundability

Horizon Tech Solutions receives an approved R&D credit of $150,000. This credit is applied against its current year Delaware tax liability of $50,000.

• Tax Liability Offset: $50,000 of the credit eliminates the company’s tax burden.
• Refund Generated: The remaining $100,000 ($150,000 total credit minus $50,000 tax liability) is, by statute, paid directly to Horizon Tech Solutions as a tax refund.2

This example highlights the financial power of the refundable credit: for a company that invested $1.5 million in Delaware R&D, $100,000 is immediately returned as non-dilutive capital.

VI. Conclusion and Recommendations for Small Business Tax Planning

Delaware’s R&D tax credit, particularly the enhanced rates available to small businesses, represents a critical financial incentive for innovation. Effective utilization requires a deep understanding of the statutory thresholds, calculation methodologies, and administrative deadlines.

A. Key Strategic Recommendations

1. Strict Growth Modeling Against the Tax Cliff: Taxpayers must proactively forecast their average annual gross receipts (AAGR) relative to the $20 million small business threshold. Exceeding this limit results in an immediate 50% reduction in the potential state credit under both calculation methodologies, a financial consequence that requires careful mitigation strategies during periods of rapid revenue growth.
2. Mandatory Annual Method Optimization: The taxpayer’s ability to elect Method A (20% incremental) or Method B (100% ASC utilization) annually should be leveraged. For firms with stable or low historical QREs, Method A maximizes the rate applied to the incremental spending. Conversely, firms experiencing substantial year-over-year QRE growth should model Method B closely, as the federal ASC methodology often yields a broader credit base against which the 100% utilization factor can be applied.
3. Prioritize Timely Compliance: Adherence to the September 15th deadline for submitting Form 2070AC is non-negotiable.11 Given the statutory $5 million annual cap on total approved credits 11, and the knowledge that the economic scope of the R&D preference far exceeds this cap, early and accurate filing is essential. Delaying the application increases the administrative risk of being subject to credit proration, reducing the final cash refund.

B. Competitive Advantage of the Refundable 20% Credit

Delaware’s decision to combine the enhanced 20% credit rate with full refundability creates a unique economic advantage for startups operating within the state. Most early-stage companies engaged in R&D, such as those in the biotechnology or high-tech sectors, operate at a net loss and have little to no tax liability.

In states offering only non-refundable R&D credits, these companies rely solely on the ability to carry forward credits for up to 15 years 6, providing zero immediate cash flow. Delaware’s policy, however, transforms the R&D expenditure—a cost on the income statement—into a predictable, direct source of working capital.2 This mechanism effectively serves as a state-sponsored venture funding tool, immediately lowering the true cost of R&D and significantly enhancing the state’s competitive edge in attracting and retaining research-intensive small businesses compared to jurisdictions offering capped or non-refundable incentives.

C. Final Compliance Checklist

Taxpayers seeking to claim the enhanced small business credit must ensure the following steps are completed for each taxable year:

• Verify compliance with the definition of “small business” (AAGR $\le \$20,000,000$).
• Ensure all claimed QREs adhere to the qualification rules of federal IRC $\S 41$.
• Perform comparative analysis of Method A (20% rate, constrained by 50% QRE floor) and Method B (100% ASC utilization) to select the optimal calculation method.
• Complete and file Delaware Form 2070AC, attached with federal Form 6765, by the statutory deadline of September 15th after the end of the taxable year.
• Upon approval, claim the credit on Delaware Form 700 and allocate the resulting cash refund to critical working capital needs.

R&D Tax Credit Preparation Services

Swanson Reed is one of the only companies in the United States to exclusively focus on R&D tax credit preparation. Swanson Reed provides state and federal R&D tax credit preparation and audit services to all 50 states.

If you have any questions or need further assistance, please call or email our CEO, Damian Smyth on (800) 986-4725.
Feel free to book a quick teleconference with one of our national R&D tax credit specialists at a time that is convenient for you.

R&D Tax Credit Audit Advisory Services

creditARMOR is a sophisticated R&D tax credit insurance and AI-driven risk management platform. It mitigates audit exposure by covering defense expenses, including CPA, tax attorney, and specialist consultant fees—delivering robust, compliant support for R&D credit claims. Click here for more information about R&D tax credit management and implementation.

Our Fees

Swanson Reed offers R&D tax credit preparation and audit services at our hourly rates of between $195 – $395 per hour. We are also able offer fixed fees and success fees in special circumstances. Learn more at https://www.swansonreed.com/about-us/research-tax-credit-consulting/our-fees/